Abiopharma

🔍 McGraner Matt (Executive)

Company: NexPoint Residential Trust, Inc. (NXRT)

Report Date: 2026-04-02

Detailed Transactions and Holdings:

• Acquired 123,900 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 123,900.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Residential Trust, Inc.
• F2: On April 2, 2026, the reporting person was granted 123,900 restricted stock units. The restricted stock units will vest one-fifth on April 2, 2027, one-fifth on February 15, 2028, one-fifth on February 15, 2029 and two-fifths on February 15, 2030. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash.
• REMARKS: Executive VP and Chief Investment Officer